Recent Research Analysts’ Ratings Changes for Docusign (DOCU)

Docusign (NASDAQ: DOCU) recently received a number of ratings updates from brokerages and research firms:

• 12/17/2025 – Docusign had its “outperform” rating reaffirmed by analysts at Cantor Fitzgerald.
• 12/17/2025 – Docusign had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 12/16/2025 – Docusign is now covered by analysts at BTIG Research. They set a “buy” rating and a $88.00 price target on the stock.
• 12/16/2025 – Docusign is now covered by analysts at BTIG Research. They set a “buy” rating and a $88.00 price target on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at Evercore ISI from $92.00 to $80.00. They now have an “in-line” rating on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at UBS Group AG from $85.00 to $75.00. They now have a “neutral” rating on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at Wedbush from $85.00 to $75.00. They now have a “neutral” rating on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at Wells Fargo & Company from $85.00 to $75.00. They now have an “equal weight” rating on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at Piper Sandler from $90.00 to $75.00. They now have a “neutral” rating on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at JPMorgan Chase & Co. from $80.00 to $78.00. They now have a “neutral” rating on the stock.
• 12/5/2025 – Docusign had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $95.00 price target on the stock.
• 12/5/2025 – Docusign had its price target lowered by analysts at Bank of America Corporation from $102.00 to $82.00. They now have a “neutral” rating on the stock.
• 12/5/2025 – Docusign had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
• 12/5/2025 – Docusign had its price target lowered by analysts at Robert W. Baird from $90.00 to $75.00. They now have a “neutral” rating on the stock.
• 11/24/2025 – Docusign was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 9,515 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total transaction of $650,159.95. Following the completion of the transaction, the chief financial officer directly owned 118,213 shares of the company’s stock, valued at $8,077,494.29. This represents a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Robert Chatwani sold 13,818 shares of Docusign stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $68.33, for a total transaction of $944,183.94. Following the completion of the sale, the insider directly owned 70,197 shares in the company, valued at $4,796,561.01. This trade represents a 16.45% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 87,542 shares of company stock worth $6,097,905. Company insiders own 1.01% of the company’s stock.

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.